Form 8-K - Current report:
SEC Accession No. 0001104659-25-096306
Filing Date
2025-10-03
Accepted
2025-10-03 06:02:22
Documents
12
Period of Report
2025-09-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2527481d3_8k.htm   iXBRL 8-K 38315
  Complete submission text file 0001104659-25-096306.txt   209516

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA epix-20250930.xsd EX-101.SCH 3020
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE epix-20250930_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epix-20250930_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2527481d3_8k_htm.xml XML 3769
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER British Columbia, Canada
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER British Columbia, Canada (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 251372021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)